Shenzhen Edge Medical Launches Hong Kong IPO to Raise HK$1.2 Billion

MT Newswires Live

2025/12/30

Shenzhen Edge Medical (HKG:2675) launched its Hong Kong initial public offering on Tuesday, aiming to raise about HK$1.20 billion.

The medical technology company is offering 27,722,200 H-shares at an offer price of HK$43.24 per share, according to a Tuesday Hong Kong bourse filing.

The offering comprises 2.8 million shares for Hong Kong investors and 24.9 million shares for international investors, subject to reallocation and the overallotment option.

The company secured 15 cornerstone investors, which committed to subscribing to $75 million worth of IPO shares.

The allocation results are expected to be announced on Jan. 7, ahead of the company's trading debut on Jan. 8.

Net proceeds will be used primarily for research and development activities and to commercialize the company's products.

Morgan Stanley Asia, GF Securities (Hong Kong), China International Capital Corporation Hong Kong Securities, CLSA, and CMBC Securities are the joint bookrunners of the IPO.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2595275274"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2595275274\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2595275274?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-30 09:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2595275274","market":"sg","top_or_hot":-1,"title":"Shenzhen Edge Medical Launches Hong Kong IPO to Raise HK$1.2 Billion","media":"MT Newswires Live","content":"<html><body><p> Shenzhen Edge Medical (HKG:2675) launched its Hong Kong initial public offering on Tuesday, aiming to raise about HK$1.20 billion.</p><p>The medical technology company is offering 27,722,200 H-shares at an offer price of HK$43.24 per share, according to a Tuesday Hong Kong bourse filing.</p><p>The offering comprises 2.8 million shares for Hong Kong investors and 24.9 million shares for international investors, subject to reallocation and the overallotment option.</p><p>The company secured 15 cornerstone investors, which committed to subscribing to $75 million worth of IPO shares.</p><p>The allocation results are expected to be announced on Jan. 7, ahead of the company's trading debut on Jan. 8.</p><p>Net proceeds will be used primarily for research and development activities and to commercialize the company's products.</p><p>Morgan Stanley Asia, <a href=\"https://laohu8.com/S/GFSEF\">GF Securities</a> (Hong Kong), China International Capital Corporation Hong Kong Securities, CLSA, and CMBC Securities are the joint bookrunners of the IPO.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shenzhen Edge Medical Launches Hong Kong IPO to Raise HK$1.2 Billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShenzhen Edge Medical Launches Hong Kong IPO to Raise HK$1.2 Billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-12-30 09:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Shenzhen Edge Medical (HKG:2675) launched its Hong Kong initial public offering on Tuesday, aiming to raise about HK$1.20 billion.</p><p>The medical technology company is offering 27,722,200 H-shares at an offer price of HK$43.24 per share, according to a Tuesday Hong Kong bourse filing.</p><p>The offering comprises 2.8 million shares for Hong Kong investors and 24.9 million shares for international investors, subject to reallocation and the overallotment option.</p><p>The company secured 15 cornerstone investors, which committed to subscribing to $75 million worth of IPO shares.</p><p>The allocation results are expected to be announced on Jan. 7, ahead of the company's trading debut on Jan. 8.</p><p>Net proceeds will be used primarily for research and development activities and to commercialize the company's products.</p><p>Morgan Stanley Asia, <a href=\"https://laohu8.com/S/GFSEF\">GF Securities</a> (Hong Kong), China International Capital Corporation Hong Kong Securities, CLSA, and CMBC Securities are the joint bookrunners of the IPO.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02675","symbol_name":"精锋医疗-B","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2595275274","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2595275274","pubTimestamp":1767059516,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shenzhen Edge Medical  launched its Hong Kong initial public offering on Tuesday, aiming to raise about HK$1.20 billion.The medical technology company is offering 27,722,200 H-shares at an offer price of HK$43.24 per share, according to a Tuesday Hong Kong bourse filing.The offering comprises 2.8 million shares for Hong Kong investors and 24.9 million shares for international investors, subject to reallocation and the overallotment option.The company secured 15 cornerstone investors, which committed to subscribing to $75 million worth of IPO shares.The allocation results are expected to be announced on Jan. 7, ahead of the company's trading debut on Jan. 8.Net proceeds will be used primarily for research and development activities and to commercialize the company's products.Morgan Stanley Asia, GF Securities , China International Capital Corporation Hong Kong Securities, CLSA, and CMBC Securities are the joint bookrunners of the IPO.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02675":"精锋医疗-B"},"translate_title":"深圳边缘医疗启动香港IPO募资12亿港元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02675":0.9},"content_text":"Shenzhen Edge Medical (HKG:2675) launched its Hong Kong initial public offering on Tuesday, aiming to raise about HK$1.20 billion.The medical technology company is offering 27,722,200 H-shares at an offer price of HK$43.24 per share, according to a Tuesday Hong Kong bourse filing.The offering comprises 2.8 million shares for Hong Kong investors and 24.9 million shares for international investors, subject to reallocation and the overallotment option.The company secured 15 cornerstone investors, which committed to subscribing to $75 million worth of IPO shares.The allocation results are expected to be announced on Jan. 7, ahead of the company's trading debut on Jan. 8.Net proceeds will be used primarily for research and development activities and to commercialize the company's products.Morgan Stanley Asia, GF Securities (Hong Kong), China International Capital Corporation Hong Kong Securities, CLSA, and CMBC Securities are the joint bookrunners of the IPO.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}